Huang Y - Search Results

1

Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.

Liu X, Xiang J, Zhu D, Jiang L, Zhou Z, Tang J, Liu X, Huang Y, Shen Y. Liu X, et al. Among authors: huang y. Adv Mater. 2016 Mar 2;28(9):1743-52. doi: 10.1002/adma.201504288. Epub 2015 Dec 14. Adv Mater. 2016. PMID: 26663349

2

Molecular-dynamics-simulation-driven design of a protease-responsive probe for in-vivo tumor imaging.

Jiang Y, Lu J, Wang Y, Zeng F, Wang H, Peng H, Huang M, Jiang H, Luo C, Huang Y. Jiang Y, et al. Among authors: huang m, huang y. Adv Mater. 2014 Dec 23;26(48):8174-8. doi: 10.1002/adma.201403547. Epub 2014 Oct 22. Adv Mater. 2014. PMID: 25338710

3

Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites.

Xu F, Zhong H, Chang Y, Li D, Jin H, Zhang M, Wang H, Jiang C, Shen Y, Huang Y. Xu F, et al. Among authors: huang y. Biomaterials. 2018 Mar;158:56-73. doi: 10.1016/j.biomaterials.2017.12.018. Epub 2017 Dec 22. Biomaterials. 2018. PMID: 29304403

4

Nano-Structural Effects on Gene Transfection: Large, Botryoid-Shaped Nanoparticles Enhance DNA Delivery via Macropinocytosis and Effective Dissociation.

Zhang W, Kang X, Yuan B, Wang H, Zhang T, Shi M, Zheng Z, Zhang Y, Peng C, Fan X, Yang H, Shen Y, Huang Y. Zhang W, et al. Among authors: huang y. Theranostics. 2019 Feb 28;9(6):1580-1598. doi: 10.7150/thno.30302. eCollection 2019. Theranostics. 2019. PMID: 31037125 Free PMC article.

5

Poly-γ-glutamic acid-based GGT-targeting and surface camouflage strategy for improving cervical cancer gene therapy.

Tan J , Wang H , Xu F , Chen Y , Zhang M , Peng H , Sun X , Shen Y , Huang Y . Tan J , et al. Among authors: huang y. J Mater Chem B. 2017 Feb 14;5(6):1315-1327. doi: 10.1039/c6tb02990f. Epub 2017 Jan 27. J Mater Chem B. 2017. PMID: 32263599

6

Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles.

Yang Y, Gao Y, Chen L, Huang Y, Li Y. Yang Y, et al. Among authors: huang y. Int J Pharm. 2011 Feb 28;405(1-2):188-95. doi: 10.1016/j.ijpharm.2010.11.047. Epub 2010 Dec 3. Int J Pharm. 2011. PMID: 21130850

7

Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer.

Wang H, Wang H, Liang J, Jiang Y, Guo Q, Peng H, Xu Q, Huang Y. Wang H, et al. Among authors: huang y. Mol Pharm. 2014 Oct 6;11(10):3352-60. doi: 10.1021/mp5001058. Epub 2014 Aug 13. Mol Pharm. 2014. PMID: 25080334

8

Drug delivery and reversal of MDR.

Huang Y, Li Y. Huang Y, et al. Mol Pharm. 2014 Aug 4;11(8):2493-4. doi: 10.1021/mp500438x. Mol Pharm. 2014. PMID: 25087942 No abstract available.

9

Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.

Pan ZZ, Wang HY, Zhang M, Lin TT, Zhang WY, Zhao PF, Tang YS, Xiong Y, Zeng YE, Huang YZ. Pan ZZ, et al. Among authors: huang yz. Acta Pharmacol Sin. 2016 Aug;37(8):1110-20. doi: 10.1038/aps.2016.48. Epub 2016 Jun 13. Acta Pharmacol Sin. 2016. PMID: 27292613 Free PMC article.

10

Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis.

Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, Zhang M, Xu Q, Wang J, Huang Y. Tang Y, et al. Among authors: huang y. ACS Appl Mater Interfaces. 2017 Aug 16;9(32):26648-26664. doi: 10.1021/acsami.7b05292. Epub 2017 Aug 3. ACS Appl Mater Interfaces. 2017. PMID: 28741923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80,889 results

Search Page

Filters